Karyopharm Therapeutics (KPTI) Current Deferred Revenue (2012 - 2020)
Karyopharm Therapeutics' Current Deferred Revenue came in at $297,000 for Q4 2020, down 87.3% from $2.34 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Current Deferred Revenue (2012 - 2020) Analysis & Trends
Going back to Q4 2012, Karyopharm Therapeutics' Current Deferred Revenue data covers 20 quarters.
- Current Deferred Revenue has declined in each of the last three years, with a three-year compound annual growth rate of -76.2% (FY2017 to FY2020).
- Going back by year, Current Deferred Revenue was $2.34 million in FY2019 (-75.0%), $9.36 million in FY2018 (-57.3%) and $21.92 million in FY2017.
- The five-year range for quarterly Current Deferred Revenue is $297,000 (Q2 2020) to $21.92 million (Q4 2017).
- Year-over-year, Current Deferred Revenue has declined for nine consecutive quarters, with an average decline of 77.5% over the last eight quarters.
- The fastest year-over-year change in Current Deferred Revenue over five years came in Q2 2018 (growth of 813.5%), and the weakest in Q3 2019 (a decline of 88.8%).
- Business Quant data shows KPTI's Current Deferred Revenue at $297,000 (Q3 2020), $297,000 (Q2 2020) and $1.29 million (Q1 2020) in the three quarters before Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Karyopharm Therapeutics | 12.16 Mn | -214.27 Mn | 32.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 297,000.00 |
| Sep 30, 2020 | 297,000.00 |
| Jun 30, 2020 | 297,000.00 |
| Mar 31, 2020 | 1.29 Mn |
| Dec 31, 2019 | 2.34 Mn |
| Sep 30, 2019 | 1.05 Mn |
| Jun 30, 2019 | 1.29 Mn |
| Mar 31, 2019 | 10.65 Mn |
| Dec 31, 2018 | 9.36 Mn |
| Sep 30, 2018 | 9.36 Mn |
| Jun 30, 2018 | 9.36 Mn |
| Mar 31, 2018 | 19.73 Mn |
| Dec 31, 2017 | 21.92 Mn |
| Sep 30, 2017 | 1.05 Mn |
| Jun 30, 2017 | 1.03 Mn |
| Sep 30, 2014 | 14,000.00 |
| Jun 30, 2014 | 36,000.00 |
| Mar 31, 2014 | 57,000.00 |
| Dec 31, 2013 | 79,000.00 |
| Dec 31, 2012 | 66,000.00 |
API Access
Karyopharm Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();